Polylactic acid composition, preparation method thereof and application of rare earth-phytic acid complex
By adding rare earth-phytic acid complexes to polylactic acid materials, the problem of polylactic acid materials lacking antibacterial properties is solved, and the effect of improving antibacterial properties and reducing cytotoxicity is achieved, while having a small impact on mechanical properties.
Patent Information
- Application Number
- CN202411264930.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-10
- Publication Date
- 2024-11-22
AI Technical Summary
In the prior art, polylactic acid materials lack antibacterial properties and are difficult to effectively apply in the field of antibacterial needs.
Rare earth-phytic acid complexes are prepared by reacting rare earth inorganic salts with phytic acid in water, and combined with polylactic acid and ester polymer compounds to form a polylactic acid composition with antibacterial properties.
The antibacterial properties of the polylactic acid composition are improved, while reducing its cytotoxicity and having a small impact on mechanical properties.
Smart Images

Figure CN118994866A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a polylactic acid composition and a preparation method thereof, and application of a rare earth-phytic acid complex. Background Art
[0002] Polylactic acid has good biodegradability and biocompatibility, making it a promising polymer material. Polylactic acid itself does not have obvious antibacterial properties, but by adding antibacterial ingredients, it can be given good antibacterial properties, thereby enabling polylactic acid to be used in fields with antibacterial needs, such as antibacterial packaging materials.
[0003] CN118005998A discloses a flame retardant composition, comprising ellagic acid-organic phosphonic acid-rare earth ternary complex, focused piperazine phosphate and guanidine salt flame retardant. The organic phosphonic acid ligand in the ellagic acid-organic phosphonic acid-rare earth ternary complex is selected from one or more of (1-hydroxyethylidene) diphosphonic acid, aminotrimethylenephosphonic acid, phytic acid and hexamethylenediaminetetramethylenephosphonic acid.
[0004] CN110144025A discloses a phytic acid rare earth catalyst composition, comprising one of an alkyl aluminum or alkyl magnesium compound and a phytic acid rare earth complex Ln8[(C6H6)H4(PO4)6]3·C2H5OH·xH2O·yL shown in formula (I); wherein Ln is a rare earth element, L is an electron-donating ligand, 10<x<15, 0<y≤4.
[0005] CN115368405A discloses a method for preparing a cerium phytate complex, comprising the following steps: (1) preparing a cerium ion aqueous solution and a phytic acid aqueous solution respectively; (2) adding the cerium ion aqueous solution to the phytic acid aqueous solution under stirring, continuing stirring until precipitation is complete, washing with ultrapure water until the washing liquid is neutral, filtering and drying to obtain a cerium phytate complex with a porous nanostructure. The cerium phytate complex is used to prepare a health product or medicine for preventing or treating liver lipid damage.
[0006] None of the above prior arts discloses that rare earth-phytic acid complexes can improve the antibacterial properties of polylactic acid. Summary of the invention
[0007] In view of this, an object of the present invention is to provide a polylactic acid composition, which has good antibacterial properties. Further, the polylactic acid composition has low cytotoxicity. Another object of the present invention is to provide a method for preparing a polylactic acid composition, which can improve the antibacterial properties of the polylactic acid composition. Another object of the present invention is to provide the use of rare earth-phytic acid complexes.
[0008] The above purpose is achieved through the following technical solutions.
[0009] In one aspect, the present invention provides a polylactic acid composition, comprising a rare earth-phytic acid complex, polylactic acid, an ester polymer compound and a plasticizer;
[0010] The rare earth-phytic acid complex is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1;
[0011] The ester polymer compound is obtained by polycondensation reaction of a dibasic acid monomer and a diol monomer;
[0012] The dibasic acid monomer includes an aliphatic dibasic acid represented by formula (I) and an aromatic dibasic acid represented by formula (II);
[0013]
[0014] wherein R1 is selected from C1 to C8 alkylene, and R2 and R3 are independently selected from C1 to C6 alkylene or a single bond;
[0015] The diol monomer is shown in formula (III):
[0016] HO—R4-OH (III);
[0017] Wherein, R4 is selected from C2 to C8 alkylene;
[0018] M is 85 to 99.5 parts by weight, and the amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight; wherein M represents the total weight of the polylactic acid, the ester polymer compound and the plasticizer.
[0019] According to the polylactic acid composition of the present invention, preferably, the mass ratio of polylactic acid, ester polymer compound and plasticizer is (60-80):(20-40):(0.5-2).
[0020] According to the polylactic acid composition of the present invention, preferably, the rare earth inorganic salt is selected from one or more of rare earth nitrates, rare earth chlorides, rare earth carbonates, and rare earth oxalates;
[0021] The plasticizer is selected from one or more of tributyl citrate and acetyl tributyl citrate.
[0022] On the other hand, the present invention provides a method for preparing the above-mentioned polylactic acid composition, comprising the following steps:
[0023] Dissolving a raw material including a composition containing polylactic acid and a rare earth-phytic acid complex in a solvent to obtain a liquid; spraying the liquid into a mold, and then drying to obtain a polylactic acid composition;
[0024] The polylactic acid-containing composition comprises polylactic acid, an ester polymer compound and a plasticizer;
[0025] The solvent is selected from one or more of dichloromethane, chloroform, tetrahydrofuran, dioxane, acetone and ethyl acetate.
[0026] According to the preparation method of the present invention, preferably, before spraying, air bubbles in the liquid are removed by ultrasonication; and the drying temperature is 20-38°C.
[0027] The preparation method according to the present invention preferably further comprises the following steps:
[0028] The polylactic acid, the ester polymer compound and the plasticizer are mixed, and then the mixture is circulated in a twin-screw extruder for 1 to 15 minutes and then extruded to obtain a composition containing polylactic acid;
[0029] The polylactic acid and ester polymer compounds are dried at 60 to 95° C. for 5 to 20 hours before being mixed with the plasticizer.
[0030] The preparation method according to the present invention preferably further comprises the following steps:
[0031] Rare earth inorganic salt and phytic acid are reacted in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1.
[0032] According to the preparation method of the present invention, preferably, a second mixed solution containing water and phytic acid is added dropwise to a first mixed solution containing water and a rare earth inorganic salt, and stirred at 20 to 38° C. for 10 to 36 hours to obtain a reaction product; the reaction product is washed and then dried to obtain a rare earth-phytic acid complex.
[0033] In another aspect, the present invention provides a use of a rare earth-phytic acid complex in improving the antibacterial properties of a composition containing polylactic acid.
[0034] The rare earth-phytic acid complex is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1;
[0035] The polylactic acid-containing composition comprises polylactic acid, an ester polymer compound and a plasticizer;
[0036] The ester polymer compound is obtained by polycondensation reaction of a dibasic acid monomer and a diol monomer;
[0037] The dibasic acid monomer includes an aliphatic dibasic acid represented by formula (I) and an aromatic dibasic acid represented by formula (II);
[0038]
[0039] wherein R1 is selected from C1 to C8 alkylene, and R2 and R3 are independently selected from C1 to C6 alkylene or a single bond;
[0040] The diol monomer is shown in formula (III):
[0041] HO-R4-OH (III);
[0042] Wherein, R4 is selected from C2 to C8 alkylene groups.
[0043] According to the use of the present invention, preferably, the amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight, and the amount of the composition containing polylactic acid is 85 to 99.5 parts by weight;
[0044] The mass ratio of polylactic acid, ester polymer compound and plasticizer is (60-80):(20-40):(0.5-2).
[0045] The polylactic acid composition of the present invention contains a rare earth-phytic acid complex, which has good compatibility with the composition containing polylactic acid of the present invention and can effectively improve the antibacterial property of the composition containing polylactic acid. Furthermore, the polylactic acid composition of the present invention has low cytotoxicity. Furthermore, the amount of the rare earth-phytic acid complex in the polylactic acid composition of the present invention is small, and has little effect on the mechanical properties of the composition. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] Figure 1 This is the infrared spectrum of the rare earth-phytic acid complex obtained in Example 1. DETAILED DESCRIPTION
[0047] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto.
[0048] <Polylactic acid composition>
[0049] The polylactic acid composition of the present invention comprises a rare earth-phytic acid complex, polylactic acid, an ester polymer compound and a plasticizer. In some embodiments, the polylactic acid composition of the present invention is composed of the above-mentioned components. The present invention finds that the rare earth-phytic acid complex has good compatibility with polylactic acid and an ester polymer compound, can effectively improve the antibacterial property of polylactic acid and an ester polymer compound, and has low cytotoxicity. The polylactic acid composition of the present invention can be a film, or can be granular, strip-shaped, etc.
[0050] The rare earth-phytic acid complex of the present invention is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex. Preferably, the following steps are also included: washing the obtained reaction product and then drying it to obtain a rare earth-phytic acid complex. The second mixed solution containing water and phytic acid can be added dropwise to the first mixed solution containing water and a rare earth inorganic salt, and stirred to obtain a reaction product.
[0051] The molar ratio of the rare earth element contained in the rare earth inorganic salt to phytic acid is (2-7):1; preferably (3-6):1; more preferably (4-5):1.
[0052] The rare earth inorganic salt can be selected from one or more of rare earth nitrates, rare earth hydrochlorides, rare earth carbonates, and rare earth oxalates. Preferably, the rare earth inorganic salt is a rare earth nitrate. The rare earth nitrate can be used in the form of its hydrate. The rare earth element in the rare earth inorganic salt is preferably lanthanum. The complex formed by such a rare earth element and phytic acid has a better antibacterial effect and has better compatibility with polylactic acid and the ester polymer compound of the present invention.
[0053] The amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight, preferably 1 to 10 parts by weight. In some embodiments, the amount of the rare earth-phytic acid complex is 4 to 7 parts by weight. This can improve the antibacterial properties of the polylactic acid composition and has little effect on its mechanical properties.
[0054] The ester polymer compound of the present invention is obtained by polycondensation reaction of dibasic acid monomers and diol monomers.
[0055] The dibasic acid monomers include aliphatic dibasic acids represented by formula (I) and aromatic dibasic acids represented by formula (II).
[0056]
[0057] In formula (I), R1 is selected from C1 to C8 alkylene groups; preferably, R1 is selected from C2 to C6 alkylene groups; more preferably, R1 is selected from C3 to C5 alkylene groups.
[0058] Examples of alkylene groups include, but are not limited to, methylene, ethylene, propylene, isopropylene, butylene, isobutylene, sec-butylene, tert-butylene, pentylene, methylbutylene, ethylpropylene, hexylene, methylpentylene, dimethylbutylene, and ethylbutylene.
[0059] According to one embodiment of the present invention, the aliphatic dibasic acid is adipic acid.
[0060]
[0061] In formula (II), R2 and R3 are independently selected from C1-C6 alkylene or a single bond. Preferably, R2 and R3 are independently selected from C1-C3 alkylene or a single bond. In certain embodiments, R2 and R3 are both single bonds.
[0062] Examples of alkylene groups include, but are not limited to, methylene, ethylene, propylene, isopropylene, butylene, isobutylene, sec-butylene, tert-butylene, pentylene, methylbutylene, ethylpropylene, hexylene, methylpentylene, dimethylbutylene, and ethylbutylene.
[0063] According to one embodiment of the present invention, the aromatic dibasic acid is terephthalic acid.
[0064] The diol monomer is shown in formula (III):
[0065] HO-R4-OH (III);
[0066] In formula (III), R4 is selected from C2 to C8 alkylene groups; preferably, R4 is selected from C3 to C6 alkylene groups; more preferably, R4 is selected from C4 to C5 alkylene groups.
[0067] Examples of alkylene groups include, but are not limited to, ethylene, propylene, isopropylene, butylene, isobutylene, sec-butylene, tert-butylene, pentylene, methylbutylene, ethylpropylene, hexylene, methylpentylene, dimethylbutylene, and ethylbutylene.
[0068] According to one embodiment of the present invention, the diol monomer is butanediol.
[0069] According to one embodiment of the present invention, the ester polymer compound is polybutylene adipate / terephthalate.
[0070] M represents the total weight of polylactic acid, ester polymer compound and plasticizer. M is 85 to 99.5 parts by weight, preferably 90 to 99 parts by weight. In some embodiments, M is 93 to 96 parts by weight.
[0071] The mass ratio of polylactic acid to plasticizer may be (60-80):(0.5-2); preferably (65-75):(0.8-1.5); more preferably (70-72):(1-1.2).
[0072] The mass ratio of the ester polymer compound to the plasticizer may be (20-40):(0.5-2); preferably (25-35):(0.8-1.5); more preferably (30-32):(1-1.2).
[0073] The plasticizer is selected from one or more of tributyl citrate and acetyl tributyl citrate. In some embodiments, the plasticizer is tributyl citrate. In other embodiments, the plasticizer is acetyl tributyl citrate.
[0074] <Method for preparing polylactic acid composition>
[0075] The preparation method of the present invention comprises the following steps: dissolving a raw material including a composition containing polylactic acid and a rare earth-phytic acid complex in a solvent to obtain a feed liquid; spraying the feed liquid in a mold, and then drying to obtain a polylactic acid composition. In some embodiments, the raw material consists of a composition containing polylactic acid and a rare earth-phytic acid complex. The composition containing polylactic acid includes polylactic acid, an ester polymer compound and a plasticizer. Preferably, the composition containing polylactic acid consists of polylactic acid, an ester polymer compound and a plasticizer. The selection and dosage of the rare earth-phytic acid complex, polylactic acid, an ester polymer compound and a plasticizer are as described above and will not be repeated here.
[0076] The solvent is selected from one or more of dichloromethane, chloroform, tetrahydrofuran, dioxane, acetone, and ethyl acetate. In certain embodiments, the solvent is selected from one or more of dichloromethane and tetrahydrofuran. According to one embodiment of the present invention, the solvent is dichloromethane.
[0077] Preferably, bubbles in the liquid are removed by ultrasonication before spraying.
[0078] The drying temperature may be 20 to 38°C, preferably 22 to 35°C, and more preferably 25 to 30°C.
[0079] In some embodiments, the method further comprises the step of preparing a rare earth-phytic acid complex by reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex. Preferably, the method further comprises the step of washing the obtained reaction product and then drying it to obtain a rare earth-phytic acid complex. The type of the rare earth inorganic salt and the molar ratio of the rare earth inorganic salt and phytic acid are as described above and will not be repeated here.
[0080] In the reaction system, the mass ratio of phytic acid to water may be 16.5:(150-350); preferably 16.5:(200-300); more preferably 16.5:(250-280).
[0081] The reaction product may be washed with water until the pH of the reaction product is neutral.
[0082] The drying temperature may be 45 to 80° C., preferably 50 to 70° C., and more preferably 60 to 65° C. The drying may be performed under vacuum.
[0083] In certain embodiments, the second mixed solution containing water and phytic acid is added dropwise to the first mixed solution containing water and rare earth inorganic salt, and stirred to obtain a reaction product.
[0084] In the first mixed solution, the mass volume ratio of the rare earth inorganic salt and water can be (30-60):200 g / mL; preferably (35-50):200 g / mL; more preferably (40-45):200 g / mL.
[0085] In the second mixed solution, the mass ratio of phytic acid to water may be 16.5:(40-70); preferably 16.5:(50-65); more preferably 16.5:(55-60).
[0086] The stirring is carried out at a temperature of 20 to 38°C, preferably 25 to 35°C.
[0087] The stirring time may be 10 to 36 hours, preferably 15 to 30 hours, and more preferably 20 to 25 hours.
[0088] In some embodiments, the method further includes preparing a composition containing polylactic acid by mixing polylactic acid, an ester polymer compound and a plasticizer, and then circulating the mixture in a twin-screw extruder for 1 to 15 minutes, preferably extruding the mixture after 5 to 10 minutes, to obtain a composition containing polylactic acid.
[0089] The temperature of the twin-screw extruder can be set to 140-220° C., preferably 150-200° C., and more preferably 160-180° C. According to one embodiment of the present invention, the temperatures of the temperature control zones of the twin-screw extruder can be set to 160° C., 170° C., and 180° C., respectively.
[0090] Before mixing with the plasticizer, the polylactic acid and ester polymer compounds can be dried at 60-95°C for 5-20 hours. This can remove the water in the polylactic acid and ester polymer compounds. The polylactic acid and ester polymer compounds can be dried and dehydrated separately or mixed and then dried and dehydrated.
[0091] The drying temperature may be 60 to 95°C, preferably 70 to 90°C, and more preferably 80 to 85°C.
[0092] The drying time may be 5 to 20 hours, preferably 10 to 15 hours, and more preferably 12 to 13 hours.
[0093] <Application of rare earth-phytic acid complex>
[0094] The rare earth-phytic acid complex of the present invention has good antibacterial properties, low cytotoxicity, and good compatibility with a composition containing polylactic acid. Therefore, the present invention provides a use of a rare earth-phytic acid complex in improving the antibacterial properties of a composition containing polylactic acid. The antibacterial properties are preferably antibacterial properties against Escherichia coli and / or Staphylococcus aureus.
[0095] The rare earth-phytic acid complex of the present invention is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex. The molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1. The preparation method of the rare earth-phytic acid complex is specifically described above and will not be repeated here.
[0096] The amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight, preferably 1 to 10 parts by weight. In some embodiments, the amount of the rare earth-phytic acid complex is 4 to 7 parts by weight. This can improve the antibacterial properties of the polylactic acid composition, have little effect on its mechanical properties, and have low cytotoxicity.
[0097] The composition containing polylactic acid of the present invention comprises polylactic acid, ester polymer compound and plasticizer. The amount of the composition containing polylactic acid and the composition containing polylactic acid are as described above, and will not be repeated here. Such composition containing polylactic acid has good compatibility with rare earth-phytic acid complex.
[0098] Here is the test method:
[0099] Antibacterial activity: Pick an appropriate amount of mature colonies (Escherichia coli and Staphylococcus aureus) and culture them in liquid culture medium at 37°C for 6-8 hours. Dilute the bacterial solution with culture medium to a bacterial count of 3×10 5 CFU / mL~4×10 5 CFU / mL. Take 5 ml of bacterial solution in 70 ml of PBS buffer, soak 0.75 g of the polylactic acid composition therein, shake and culture for 18 hours, take the bacterial solution in the culture solution, and count the plate to confirm the antibacterial rate.
[0100] Cytotoxicity: 3T3 cells were tested at 1×10 4The cells were seeded at a density of 1000 cells / well in a 96-well plate and incubated overnight in a cell culture incubator. The culture medium was removed, and the extract or cell culture medium formed by different masses of the polylactic acid composition was added, and the incubation was continued for 24 hours, and the cell survival rate was determined by the CCK-8 method. The extract of the polylactic acid composition was obtained by the following method: the polylactic acid composition of different masses was immersed in 5 mL of cell culture medium and oscillated for extraction for 24 hours to obtain an extract; the mass of the polylactic acid composition was measured by the mass of the rare earth-phytic acid complex it contained. The method of double dilution was used to test the cell survival rate. The cell survival rate under the extract formed by different masses of the polylactic acid composition was calculated based on the cell survival rate when the cell culture medium was used as the culture medium.
[0101] Example 1
[0102] (1) 43.3 g of lanthanum nitrate hexahydrate was mixed with 200 mL of water to obtain a first mixed solution. A phytic acid aqueous solution with a concentration of 70 wt% was mixed with 50 mL of water to obtain a second mixed solution. The content of phytic acid in the second mixed solution was 16.5 g.
[0103] The second mixed solution was added dropwise to the first mixed solution, and then stirred at 25°C for 24 hours to obtain a reaction product. The reaction product was washed with water until the pH was neutral, and then vacuum dried at 60°C to obtain a rare earth-phytic acid complex. The infrared spectrum of the obtained rare earth-phytic acid complex is as follows: Figure 1 shown.
[0104] (2) Polylactic acid and PBAT (polybutylene adipate / terephthalate) were dried at 80°C for 12 hours to obtain dehydrated polylactic acid and dehydrated PBAT. 70 parts by weight of dehydrated polylactic acid, 30 parts by weight of dehydrated PBAT and 1 part by weight of tributyl citrate were mixed and then extruded after circulating in a twin-screw extruder for 5 minutes to obtain a composition containing polylactic acid. The temperatures of each temperature control zone of the twin-screw extruder were set to 160°C, 170°C and 180°C, respectively.
[0105] (3) 99 parts by weight of the composition containing polylactic acid obtained by the method of step (2) and 1 part by weight of the rare earth-phytic acid complex obtained by the method of step (1) are dissolved in dichloromethane to obtain a liquid. The liquid is ultrasonically deaerated to remove bubbles. The liquid after deaeration is uniformly sprayed on a mold, and then dried at 25° C. to obtain a polylactic acid composition. The antibacterial activity of the polylactic acid composition is shown in Table 1, and the cell survival rate is shown in Table 2.
[0106] Example 2
[0107] Except that the amount of the composition containing polylactic acid in step (3) is 95 parts by weight and the amount of the rare earth-phytic acid complex is 5 parts by weight, the rest is the same as in Example 1. The antibacterial activity of the polylactic acid composition is shown in Table 1, and the cell survival rate is shown in Table 2.
[0108] Example 3
[0109] Except that the amount of the composition containing polylactic acid in step (3) is 90 parts by weight and the amount of the rare earth-phytic acid complex is 10 parts by weight, the rest is the same as in Example 1. The antibacterial activity of the polylactic acid composition is shown in Table 1, and the cell survival rate is shown in Table 2.
[0110] Example 4
[0111] Except that dichloromethane was replaced by tetrahydrofuran in step (3), the rest was the same as Example 3. The antibacterial activity of the polylactic acid composition is shown in Table 1, and the cell survival rate is shown in Table 2.
[0112] Comparative Example 1
[0113] (1) Polylactic acid and PBAT (polybutylene adipate / terephthalate) were dried at 80°C for 12 hours to obtain dehydrated polylactic acid and dehydrated PBAT. 70 parts by weight of dehydrated polylactic acid, 30 parts by weight of dehydrated PBAT and 1 part by weight of tributyl citrate were mixed, and then extruded after circulating in a twin-screw extruder for 5 minutes to obtain a composition containing polylactic acid. The temperatures of each temperature control zone of the twin-screw extruder were set to 160°C, 170°C and 180°C, respectively.
[0114] (2) 100 parts by weight of the composition containing polylactic acid obtained by the above method was dissolved in dichloromethane to obtain a liquid. The liquid was ultrasonically deaerated. The liquid after deaeration was uniformly sprayed on a mold, and then dried at 25° C. to obtain a polylactic acid composition. The antibacterial activity of the polylactic acid composition is shown in Table 1, and the cytotoxicity is shown in Table 2.
[0115] Table 1
[0116]
[0117] Table 2
[0118]
[0119] The present invention is not limited to the above-mentioned embodiments. Without departing from the essential content of the present invention, any deformation, improvement and substitution that can be thought of by those skilled in the art shall fall within the scope of the present invention.
Claims
1. A polylactic acid composition, It is characterized in that The polylactic acid composition comprises a rare earth-phytic acid complex, polylactic acid, an ester polymer compound and a plasticizer; The rare earth-phytic acid complex is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1; The ester polymer compound is obtained by polycondensation reaction of a dibasic acid monomer and a diol monomer; The dibasic acid monomer includes an aliphatic dibasic acid represented by formula (I) and an aromatic dibasic acid represented by formula (II); Among them, R 1 is selected from C1-C8 alkylene, R 2 and R 3 Each is independently selected from a C1-C6 alkylene group or a single bond; The diol monomer is shown in formula (III): HO—R 4 —OH (III); Among them, R 4 An alkylene group selected from C2 to C8; M is 85 to 99.5 parts by weight, and the amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight; wherein M represents the total weight of the polylactic acid, the ester polymer compound and the plasticizer.
2. The polylactic acid composition according to claim 1, It is characterized in that The mass ratio of polylactic acid, ester polymer compound and plasticizer is (60-80):(20-40):(0.5-2).
3. The polylactic acid composition according to claim 1, It is characterized in that The rare earth inorganic salt is selected from one or more of rare earth nitrates, rare earth chlorides, rare earth carbonates, and rare earth oxalates; The plasticizer is selected from one or more of tributyl citrate and acetyl tributyl citrate.
4. A method for preparing a polylactic acid composition according to any one of claims 1 to 3, It is characterized in that The steps include: Dissolving a raw material including a composition containing polylactic acid and a rare earth-phytic acid complex in a solvent to obtain a liquid; spraying the liquid into a mold, and then drying to obtain a polylactic acid composition; The polylactic acid-containing composition comprises polylactic acid, an ester polymer compound and a plasticizer; The solvent is selected from one or more of dichloromethane, chloroform, tetrahydrofuran, dioxane, acetone and ethyl acetate.
5. The preparation method according to claim 4, It is characterized in that Before spraying, air bubbles in the liquid are removed by ultrasonic method; the drying temperature is 20-38°C.
6. The preparation method according to claim 4, It is characterized in that The following steps are also included: The polylactic acid, the ester polymer compound and the plasticizer are mixed, and then the mixture is circulated in a twin-screw extruder for 1 to 15 minutes and then extruded to obtain a composition containing polylactic acid; The polylactic acid and ester polymer compounds are dried at 60 to 95° C. for 5 to 20 hours before being mixed with the plasticizer.
7. The preparation method according to claim 4, It is characterized in that The following steps are also included: Rare earth inorganic salt and phytic acid are reacted in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):
1.
8. The preparation method according to claim 7, It is characterized in that The second mixed solution containing water and phytic acid is added dropwise to the first mixed solution containing water and rare earth inorganic salt, and stirred at 20-38° C. for 10-36 hours to obtain a reaction product; the reaction product is washed and then dried to obtain a rare earth-phytic acid complex.
9. Use of a rare earth-phytic acid complex in improving the antibacterial properties of a composition containing polylactic acid, Features: The rare earth-phytic acid complex is prepared by the following method: reacting a rare earth inorganic salt and phytic acid in water to obtain a rare earth-phytic acid complex; the molar ratio of the rare earth element contained in the rare earth inorganic salt to the phytic acid is (2-7):1; The polylactic acid-containing composition comprises polylactic acid, an ester polymer compound and a plasticizer; The ester polymer compound is obtained by polycondensation reaction of a dibasic acid monomer and a diol monomer; The dibasic acid monomer includes an aliphatic dibasic acid represented by formula (I) and an aromatic dibasic acid represented by formula (II); Among them, R 1 is selected from C1-C8 alkylene, R 2 and R 3 Each is independently selected from a C1-C6 alkylene group or a single bond; The diol monomer is shown in formula (III): HO—R 4 —OH (III); Among them, R 4 An alkylene group selected from C2 to C8.
10. The use according to claim 9, It is characterized in that The amount of the rare earth-phytic acid complex is 0.5 to 15 parts by weight, and the amount of the composition containing polylactic acid is 85 to 99.5 parts by weight; The mass ratio of polylactic acid, ester polymer compound and plasticizer is (60-80):(20-40):(0.5-2).
